| AAb/AAbs | autoantibody/autoantibodies |
| ACE | angiotensin-converting enzyme |
| ACM | arrhythmogenic cardiomyopathy |
| AF | atrial fibrillation |
| AHA/s | anti-heart autoantibody/autoantibodies |
| AIDA/s | anti-intercalated disk autoantibody/autoantibodies |
| ALVC | arrhythmogenic left ventricular cardiomyopathy |
| AMA/s | anti-myosin autoantibody/autoantibodies |
| APCs | antigen-presenting cells |
| AT1R | angiotensin II type 1 receptor |
| AT1R-AAbs | autoantibodies against AT1R |
| AT2R-AAbs | autoantibodies against angiotensin II type 2 receptor |
| βAR/βARs | β-adrenergic receptor/s |
| β1AR | β1-adrenergic receptor |
| β1AR-AAbs | autoantibodies against β1AR |
| β2AR | β2-adrenergic receptor |
| β2AR-AAbs | autoantibodies against β2AR |
| cAMP | cyclic adenosine monophosphate |
| CMR | cardiac magnetic resonance |
| COX-2 | cyclooxygenase-2 |
| COVID-19 | coronavirus disease 2019 |
| CRT | calreticulin |
| cTn | cardiac troponin |
| cTnI | cardiac troponin I |
| cTnT | cardiac troponin T |
| DCM | dilated cardiomyopathy |
| DSC2 | desmocollin-2 |
| DSG2 | desmoglein-2 |
| DSP | desmoplakin |
| ELISA | enzyme-linked immunosorbent assay |
| EMB | endomyocardial biopsy |
| ER | endoplasmic reticulum |
| ESC | European Society of Cardiology |
| ETAR | endothelin-1 type A receptor |
| ETAR-AAbs | autoantibodies against ETAR |
| FCM | Fabry cardiomyopathy |
| GDMT | guideline-directed medical therapy |
| GPCR/s | G protein-coupled receptor/s |
| GPCR-AAbs | G protein-coupled receptor autoantibodies |
| HF | heart failure |
| HCM | hypertrophic cardiomyopathy |
| HFrEF | heart failure with reduced ejection fraction |
| HTx | heart transplantation |
| IA | immunoadsorption |
| IDs | intercalated discs |
| IHD | ischemic heart disease |
| iNOS | inducible nitric oxide synthase |
| JUP | plakoglobin |
| LV | left ventricular |
| LVAD | left ventricular assist device |
| LVEF | left ventricular ejection fraction |
| LVNC | left ventricular non-compaction |
| MACEs | major adverse cardiac events |
| MAPK/ERK | mitogen-activated protein kinase/extracellular signal-regulated kinase |
| MHC | myosin heavy chain |
| M2R | muscarinic M2 receptor |
| M2R-AAbs | autoantibodies against M2R |
| NDLVC | non-dilated left ventricular cardiomyopathy |
| NT-proBNP | N-terminal pro-B-type natriuretic peptide |
| NYHA | New York Heart Association |
| PKA | protein kinase A |
| PKP2 | plakophilin-2 |
| PVCs | premature ventricular contractions |
| RCM | restrictive cardiomyopathy |
| SCD | sudden cardiac death |
| TPE | therapeutic plasma exchange |
| TTS | Takotsubo syndrome |